Mycoplasma Genitalium: A Complete Medical Overview

Mycoplasma genitalium is a sexually transmitted bacterial infection that can affect the urethra, cervix, and sometimes the rectum. It often causes no symptoms, but when symptoms do occur, they may include burning with urination, discharge, pelvic discomfort, or bleeding after sex.

Overview

Mycoplasma genitalium is a small bacterium that is spread through sexual contact. It is now recognized as an important cause of genital tract infection, especially in people with ongoing urethritis, cervicitis, or symptoms that continue after treatment for other common sexually transmitted infections. Because many people feel completely well, the infection can be passed on without anyone realizing it.

This infection most often affects the urethra in men and the cervix in women, but it may also involve the rectum. In some cases, it is linked to pelvic inflammatory disease. Unlike some better-known STIs, mycoplasma genitalium is not always included in routine screening panels, so testing is usually considered when symptoms persist, when standard STI tests are negative, or when a clinician has a strong reason to suspect it.

A useful way to understand mycoplasma genitalium is to think of it as a less familiar but clinically relevant STI that can mimic other infections. Symptoms may overlap with gonorrhea or chlamydia, but management is different because this bacterium often shows resistance to commonly used antibiotics. For that reason, accurate diagnosis matters.

Symptoms and possible complications

Many people with mycoplasma genitalium have no symptoms at all. When symptoms do occur, they can vary by the area affected. In men, the infection commonly causes urethritis, which may lead to burning or pain during urination, a discharge from the penis, irritation at the tip of the penis, or discomfort that comes and goes.

In women, mycoplasma genitalium may cause cervicitis. Symptoms can include unusual vaginal discharge, bleeding after sex, bleeding between periods, pain with urination, or pelvic discomfort. Some women may develop signs of upper genital tract involvement, such as more persistent lower abdominal pain, especially if pelvic inflammatory disease develops.

If the rectum is involved, symptoms may include rectal discomfort, discharge, or pain, though many rectal infections also remain asymptomatic. Rarely, symptoms may be subtle and mistaken for irritation, recurrent urinary discomfort, or another STI.

Potential complications depend on the site and duration of infection. In women, untreated infection may contribute to pelvic inflammatory disease, which can affect reproductive health. In men, persistent urethritis can be uncomfortable and frustrating. A doctor may also consider related conditions such as urinary tract infection when symptoms overlap, but urine symptoms alone do not confirm the cause.

How it spreads and who is at higher risk

Mycoplasma genitalium spreads through sexual contact, including vaginal and anal sex. Transmission through oral sex appears less clearly established than for some other STIs, but clinicians focus mainly on genital and rectal exposure. The infection can be passed even when a person has no symptoms.

Risk is higher in people with a new sexual partner, multiple partners, inconsistent condom use, or a recent diagnosis of another STI. A history of persistent or recurrent urethritis or cervicitis can also raise suspicion for this infection, especially when tests for more common causes are negative.

It is important to know that having mycoplasma genitalium does not necessarily mean symptoms will be severe. In fact, one of the reasons it can be overlooked is that people may feel well for long periods. Even so, identifying and treating it appropriately can reduce ongoing irritation, lower the chance of reinfection between partners, and help prevent complications.

Because antibiotic resistance is a growing issue worldwide, self-treating with leftover antibiotics or repeating earlier treatment without medical advice is not recommended. A clinician will consider symptoms, test availability, and local guidance before choosing the most suitable approach.

Diagnosis and testing

Testing for mycoplasma genitalium usually relies on a nucleic acid amplification test, often called a NAAT. This test looks for the genetic material of the bacterium and is more accurate than routine methods such as standard bacterial culture, which is not practical for this organism. Depending on symptoms and anatomy, samples may come from urine, a vaginal or cervical swab, a urethral swab, or a rectal swab.

Doctors do not usually test everyone routinely for mycoplasma genitalium. Instead, testing is often reserved for people with persistent or recurrent symptoms, those with ongoing urethritis or cervicitis, or patients in whom common causes such as chlamydia and gonorrhea have already been excluded. Some laboratories may also offer resistance testing, which can help guide antibiotic choice.

Diagnosis often involves more than one step. A clinician may ask about symptoms, sexual history, prior STI treatment, and whether a partner has been diagnosed with an infection. They may also recommend broader sexual health testing, since symptoms of mycoplasma genitalium can overlap with other conditions and coinfections are possible. In some cases, a sexual health check-up or microbiology and infectious disease evaluation can help clarify the diagnosis and treatment plan.

It is generally best to avoid guessing based on symptoms alone. Burning with urination or unusual discharge can have several causes, and proper testing helps ensure that treatment is both effective and appropriate.

Treatment options

Mycoplasma genitalium is treated with antibiotics, but treatment is more complex than for some other bacterial STIs because resistance is common. The exact antibiotic plan depends on regional guidance, available resistance testing, previous antibiotics used, pregnancy status, allergies, and whether symptoms are uncomplicated or linked to complications such as pelvic inflammatory disease.

In many cases, clinicians use a staged or tailored antibiotic approach rather than a single standard medicine for everyone. This may involve one antibiotic first to reduce bacterial load, followed by a second antibiotic chosen according to likely or confirmed resistance patterns. It is important for patients to take the full course exactly as prescribed and not stop treatment early just because symptoms improve.

Sexual partners may also need evaluation and treatment. This step helps reduce the risk of passing the infection back and forth. Patients are usually advised to avoid sexual contact, or to follow their doctor’s instructions about timing, until treatment is completed and it is considered safe to resume sex.

Follow-up may include a test of cure in selected situations, especially if symptoms continue, resistance is suspected, adherence was uncertain, or local recommendations support repeat testing. When pelvic pain, persistent bleeding, or more complex reproductive tract symptoms are present, a clinician may also coordinate care with gynecology or urology specialists as needed.

Prevention and self-care

The most effective way to lower the risk of mycoplasma genitalium is to practice safer sex. Consistent condom use can reduce transmission, although no method outside abstinence removes risk completely. Open communication with partners about symptoms, recent STI diagnoses, and testing can also support prevention.

People who are being treated should follow medical advice carefully. This includes taking medication exactly as prescribed, avoiding sexual activity when advised, and making sure partners are informed if partner testing or treatment is recommended. Reinfection can happen, so completing treatment is only one part of prevention.

Self-care should focus on comfort and avoiding actions that may complicate recovery. It is sensible to avoid self-prescribing antibiotics, douching, or relying on internet remedies. If symptoms such as discharge, burning, pelvic pain, or bleeding continue after treatment, follow-up is important because persistent symptoms may reflect resistance, reinfection, or a different diagnosis.

Routine general health measures still matter. Staying informed about STI testing, attending regular health visits when sexually active, and seeking medical advice promptly for new symptoms can help protect both individual and partner health.

When to seek medical care

Medical care is advisable if a person has burning with urination, genital discharge, bleeding after sex, pelvic pain, testicular discomfort, or rectal symptoms after sexual exposure. It is also reasonable to seek advice after a partner is diagnosed with mycoplasma genitalium or another STI, even if there are no symptoms.

Prompt assessment is especially important if symptoms are persistent, keep returning, or did not improve after earlier treatment for a presumed STI. Women should seek care sooner if pelvic pain, fever, or abnormal bleeding develops, since these symptoms may suggest pelvic inflammatory disease and need timely evaluation.

People should also contact a doctor if they are pregnant, have multiple recent partners, or have other medical conditions that may affect infection management. A qualified clinician can determine which tests are appropriate and whether treatment is needed.

For international patients who need coordinated evaluation, Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat sexually transmitted and genitourinary conditions with individualized care plans.

Frequently asked questions

What is mycoplasma genitalium?

Mycoplasma genitalium is a bacterium that spreads through sexual contact and can infect the urethra, cervix, and sometimes the rectum. It is a recognized cause of urethritis and cervicitis, and many people do not notice any symptoms.

Is mycoplasma genitalium the same as chlamydia or gonorrhea?

No. It is a different bacterium, although it can cause similar symptoms such as discharge or burning with urination. This distinction matters because testing and antibiotic treatment may differ, especially due to resistance patterns.

Can you have mycoplasma genitalium without symptoms?

Yes. Many people with mycoplasma genitalium feel completely well, which is one reason the infection can be passed on unknowingly. Even without symptoms, a doctor may recommend testing in certain situations, such as after a partner’s diagnosis or with persistent unexplained genital symptoms.

How is mycoplasma genitalium diagnosed?

It is usually diagnosed with a nucleic acid amplification test, or NAAT, using urine or a swab sample depending on the symptoms and site of infection. It is not reliably identified by routine urine testing or standard bacterial culture.

Is mycoplasma genitalium curable?

In many cases, yes, but treatment can be more complicated than with some other bacterial STIs. A doctor may choose antibiotics based on likely resistance patterns or test results, and follow-up may be needed if symptoms persist.

Should sexual partners be treated too?

Partners often need medical evaluation and may also need treatment. This helps reduce the risk of reinfection and ongoing transmission. A clinician can advise how partners should be informed and when it is safe to resume sexual activity.

When should someone get tested for mycoplasma genitalium?

Testing is often considered when a person has persistent urethritis, cervicitis, pelvic symptoms, or recurrent symptoms after negative tests or treatment for other STIs. It may also be appropriate after exposure to an infected partner, depending on medical guidance.

References

• Centers for Disease Control and Prevention
• World Health Organization
• European Centre for Disease Prevention and Control
• International Union against Sexually Transmitted Infections
• American College of Obstetricians and Gynecologists

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.